1. Use Extractables and Leachables Terms Precisely
Extractables are chemical species that can be released from a material under specified laboratory conditions. Leachables are species that migrate into a process stream or product during actual or simulated use. An extractables profile helps identify potential migrants; it does not establish that every detected compound will appear in the process.
For chromatography, potential sources include the resin matrix, immobilized ligand or spacer, residual manufacturing reagents, preservatives, column and skid components, tubing, seals, filters, bags, and cleaning-related degradation products. Consider the entire product-contact path rather than testing resin in isolation when the question concerns process exposure.
Separate E&L from ligand leakage and carryover
Ligand leakage is a specific material-related impurity and may require a targeted assay. Product carryover originates from prior process material. Both can coexist with small-molecule or oligomeric leachables, but their mechanisms and controls differ.
2. Define the Assessment Scope and Decision
State the process step, product contact, route and stage of manufacture, maximum contact time, temperature, pH, solvents, salts, cleaning agents, resin reuse, and storage. Identify whether the assessment supports material selection, a process change, lifetime justification, or investigation of an analytical signal.
Use quality risk management to prioritize questions. Consider proximity to final product, downstream clearance, dose or exposure, patient population, chemical hazard, product sensitivity, and uncertainty in material composition. A research purification step and a late-stage manufacturing step can require different depth of assessment.
Define who will interpret chemical identity and exposure. Analytical detection is not a toxicological conclusion. Unknown peaks, tentative identifications, and compounds without reference standards require an explicit process for evaluation.
3. Build a Complete Product-Contact Material Map
List resin components and other product-contact materials with supplier, grade, lot, surface area or volume where meaningful, and exposure sequence. Include preservatives and processing aids that may remain in the supplied resin. Request composition and extractables information at a level appropriate to the intended use and confidentiality arrangements.
Document packaging and storage because migrants can originate before the resin is packed. If supplied slurry is transferred through disposable components, those materials can contribute to the first rinse. Different container sizes or closure systems may change contact ratios.
Identify changes over lifecycle: repeated alkaline cleaning, oxidizing agents, solvents, heat, radiation where applicable, and long storage can alter material surfaces. A pristine-material study may not represent an aged bed. Connect the plan to resin lifetime and cleaning history.
4. Select Extraction Conditions with Scientific Purpose
Use conditions that provide useful coverage without creating irrelevant destruction. Include process-simulating solutions and, where justified, exaggerated conditions that increase migration while preserving interpretability. Define solvent composition, pH, temperature, time, surface-area or resin-volume ratio, agitation, and number of contacts.
Harsh conditions can generate degradation products that never form during use. That information may still support material understanding, but should not be reported as expected process leachables. Label each condition as simulated, accelerated, or exaggerated and explain the relationship to actual operation.
Consider sequential use. Initial rinses may remove manufacturing residues, while later cleaning cycles can generate new species or expose internal surfaces. Sample meaningful lifecycle points rather than assuming the first extraction represents all cycles.
5. Use Complementary Analytical Coverage
No single analytical method detects all organic, inorganic, volatile, nonvolatile, ionic, and oligomeric compounds. A broad screen may combine complementary chromatographic and spectrometric approaches with targeted methods for known risks. Analytical choices should match expected chemistry and decision thresholds.
Establish blanks for solvents, vessels, sample preparation, and the test system. Laboratory background can create common contaminants that are easily misassigned to the resin. Use procedural blanks and track features across conditions and replicates.
Evaluate extraction recovery, matrix effects, detection capability, calibration where quantitative results are needed, and identification confidence. A library match is not the same as confirmation with an authentic standard. Report unknowns and semi-quantitative estimates transparently.
6. Design Leachables Sampling around the Process
Sample actual or simulated process streams at locations that answer the exposure question: initial rinse, equilibration, product pool, cleaning effluent, post-clean blank, or late-lifetime cycle. Avoid diluting a transient high concentration into a large composite unless the final exposure is genuinely represented by that composite.
Control sample containers, holds, shipping, and freeze-thaw because the analytical sample itself can gain or lose compounds. Use matched blanks and time-zero controls. Preserve the connection between each sample and resin lot, cycle, flow path, and process condition.
Assess downstream clearance when relevant, but demonstrate it with appropriate evidence. A compound detected before later purification is not automatically present in final product; absence in final product depends on method sensitivity and sampling. Keep clearance and safety conclusions separate.
7. Connect Analytical Results to Exposure and Product Risk
Estimate potential exposure using measured or conservatively estimated concentration, process volume, pooling, downstream clearance, dose, and frequency. Use consistent units and identify assumptions. An extract concentration measured at an exaggerated surface-area ratio should not be copied directly into a patient-exposure calculation.
| Question | Evidence needed | Common error |
|---|---|---|
| What is present? | Identification confidence and blanks | Treating a tentative match as confirmed |
| How much could migrate? | Quantitation or justified estimate | Using instrument response without response-factor context |
| Does it reach product? | Process sampling or clearance evidence | Assuming downstream removal |
| Is it acceptable? | Exposure and qualified toxicological assessment | Equating detection with unacceptable risk |
Also assess effects on product quality, activity, assay interference, and downstream processing. A compound can matter through process performance even when toxicological exposure is low.
8. Reassess E&L after Relevant Changes
Potential triggers include new resin or supplier, altered matrix or ligand chemistry, manufacturing-site change, preservative or packaging change, new cleaning chemistry, longer storage, increased reuse, and modified process contact time or temperature. Map the change to existing knowledge before deciding the scope of additional work.
Bridge analytically when the prior profile and new material can be compared meaningfully. Targeted testing may be sufficient when a specific change introduces a known risk; a broader screen may be appropriate when composition or degradation pathways are uncertain.
Document why no additional testing is needed when existing data remain representative. Absence of testing should be a reasoned conclusion, not an assumption that the product name guarantees unchanged composition.
9. Ask Suppliers Questions That Support the Assessment
Request controlled information on material composition, manufacturing residues, preservatives, extraction studies, analytical methods, lot representativeness, and change notification. Clarify whether data apply to the exact grade, supplied form, packaging, and manufacturing site.
Confidential composition can be addressed through appropriate agreements or supplier-led toxicological support. A summary statement may be useful, but understand its tested conditions and decision basis. Do not treat a general biocompatibility or food-contact statement as a process-specific E&L assessment.
When evaluating custom resin development, include E&L questions early. Ligand synthesis, activation chemistry, coupling, blocking, washing, and storage can introduce distinct potential residues. Early material knowledge makes later analytical plans more focused.
10. Translate an Extractables Signal into a Process Question
Suppose a broad extraction study detects an unknown semi-volatile feature after exaggerated alkaline exposure. The result does not establish that the compound enters the product pool. First verify that the feature is absent or much lower in procedural blanks, confirm repeatability, and assess identification confidence. Review whether the harsh condition changes the matrix or ligand in a way that routine cleaning does not.
Next design targeted sampling under the intended process lifecycle: post-clean rinse, equilibrated blank, representative product pool, and a later-cycle sample. Use containers and preparation controls that do not contribute the same feature. If the compound is absent above an appropriate detection capability, document what exposure and method sensitivity the result covers.
When the feature appears in process samples
Estimate concentration with a justified response factor or authentic standard where possible. Track the compound through downstream operations and determine the exposure represented by the final accepted product. Distinguish removal, dilution, degradation, and analytical non-detection. A lower signal after a later step does not by itself identify the mechanism.
Assess potential product-quality effects as well as toxicological exposure. The compound may interfere with an assay, modify a protein, or change stability at concentrations below a general safety concern. Involve suitable analytical, toxicological, and product experts rather than assigning acceptability from detection alone.
If the signal increases with cycle count, compare cumulative cleaning exposure, storage, and resin performance. It may indicate degradation or desorption of a manufacturing residue. If it appears only in initial rinses, evaluate whether a defined pre-use wash adequately controls it and whether the supplier lot profile is consistent.
Unknowns should retain their uncertainty. Report tentative structural class, confidence, estimated level, and the assumptions used in exposure calculations. Define the additional evidence needed for a final conclusion and avoid naming a compound solely from a weak library match.
The investigation closes by linking the finding to a control: supplier specification or change commitment, pre-use rinse, lifecycle limit, targeted monitoring, downstream clearance, or material replacement. The chosen control should address the demonstrated exposure pathway and be reviewed when process contact or material composition changes.
11. Maintain an E&L Knowledge Package
Retain material maps, supplier data, protocols, raw analytical files, blanks, identification confidence, quantitative calculations, toxicological assessments, process-clearance evidence, deviations, and conclusions. Link every dataset to material lot and exposure condition.
State the limits of the assessment: undetected chemical classes, uncertain identities, untested lifecycle points, or assumptions about downstream clearance. Define monitoring or change triggers that manage those uncertainties. A transparent boundary is more useful than a broad claim that the resin has no leachables.
Coordinate analytical, toxicological, process, quality, and sourcing expertise. The final conclusion should answer the original process decision and identify any required controls, specifications, rinsing, monitoring, or supplier commitments.
Set analytical evaluation thresholds with a clear basis and do not confuse a reporting threshold with an acceptance threshold. The former determines which signals are documented or identified; the latter requires exposure, hazard, product, and process context. Preserve signals below a reporting threshold in raw data when method capability permits, because future knowledge or material changes may justify reexamination.
Consider mixtures and cumulative exposure where relevant. Several low-level compounds can share a toxicological endpoint or interact with product quality. Expert assessment should determine when grouping is appropriate rather than adding unrelated concentrations automatically. Keep the calculation traceable from sample result through process volume and final exposure.
Use orthogonal confirmation for a compound that drives a major decision. Confirm retention behavior, mass spectral evidence, reference standard where available, and blank controls. For an unknown that cannot be fully identified, use conservative estimates and state uncertainty instead of assigning a false exact identity.
Finally, define how new supplier information enters the knowledge package. Updated extraction data, composition changes, complaint trends, or revised toxicological information can alter the assessment even when the chromatography method is unchanged. Assign periodic ownership rather than treating the report as a static one-time artifact.
Do not overlook inorganic species. Residual metals, counterions, catalysts, or mineral components may require techniques different from organic screening and can affect product oxidation, aggregation, or analytical assays. Select targeted inorganic analysis when material composition, manufacturing chemistry, or an observed process effect provides a plausible basis. Integrate those results into the same exposure and product-quality assessment instead of maintaining an isolated analytical report. Document detection limits and blank contributions for these methods as carefully as for organic screens.
Frame an E&L assessment around actual process exposure
Share the resin, flow path, process and cleaning conditions, lifecycle, downstream clearance, and intended use to identify the key analytical questions.
References
- ICH. Q9(R1): Quality Risk Management. 2023.
- FDA. Container Closure Systems for Human Drugs and Biological Products: Chemistry, Manufacturing, and Controls Documentation. 2025.
- ICH. Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. 2000.
